Clinical Trials Logo
  1. Home
  2. Hyperparathyroidism, Primary
  3. NCT04895631

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Hyperparathyroidism, Primary Clinical Trial

Official title:
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Clinical Trial Summary

This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.

Clinical Trial Description

PRIMARY OBJECTIVE: I. To investigate the performance (accuracy) of 18F-fluorocholine PET in the detection of hyperfunctioning parathyroid glands in surgical patients with biochemically proven primary hyperparathyroidism. OUTLINE: Participants will receive a single dose of 18F-Fluorocholine at the time the participant undergoes a single imaging study using 18F-fluorocholine. Study related procedures will end after the study visit. Participants who undergo subsequent parathyroidectomy, will have the results reviewed and compared to the results from the imaging study ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04895631
Study type Interventional
Source University of California, San Francisco
Contact Daniel Thompson
Phone 415-514-8995
Email fch@ucsf.edu
Status Recruiting
Phase Phase 3
Start date June 30, 2021
Completion date June 30, 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT03764007 - 18F-Fluorocholine for the Detection of Parathyroid Adenomas Phase 2/Phase 3
Not yet recruiting NCT05556499 - The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
Completed NCT00928408 - PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
Completed NCT00936988 - A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism Phase 2
Completed NCT00936650 - A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) Phase 2
Recruiting NCT04948671 - Primary Hyperparathyroidism and Gut Microbiota
Completed NCT02417389 - Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism Phase 4
Completed NCT00975221 - Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy Phase 3
Not yet recruiting NCT04126954 - Study on the Use of Cinacalcet in Phosphocalcic Context.
Recruiting NCT05152927 - Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy N/A
Recruiting NCT06230380 - Autofluorescence in Surgery for Primary Hyperparathyroidism N/A
Completed NCT03091140 - Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism.
Completed NCT03324893 - FCH PET/MRI Parathyroid Localization N/A
Completed NCT05347082 - Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment N/A